molecular function |
| GO:0016303 | | 1-phosphatidylinositol-3-kinase activity | | Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol + ATP = a 1-phosphatidyl-1D-myo-inositol 3-phosphate + ADP + 2 H(+). |
| GO:0031748 | | D1 dopamine receptor binding | | Interacting selectively and non-covalently with a D1 dopamine receptor. |
| GO:0005070 | | SH3/SH2 adaptor activity | | Interacting selectively and non-covalently and simultaneously with one or more signal transduction molecules, usually acting as a scaffold to bring these molecules into close proximity either using their own SH2/SH3 domains (e.g. Grb2) or those of their target molecules (e.g. SAM68). |
| GO:0016787 | | hydrolase activity | | Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3. |
| GO:0005158 | | insulin receptor binding | | Interacting selectively and non-covalently with the insulin receptor. |
| GO:0043560 | | insulin receptor substrate binding | | Interacting selectively and non-covalently with any of the insulin receptor substrate (IRS) proteins, adaptor proteins that bind to the transphosphorylated insulin and insulin-like growth factor receptors, are themselves phosphorylated and in turn recruit SH2 domain-containing signaling molecules to form a productive signaling complex. |
| GO:0004726 | | non-membrane spanning protein tyrosine phosphatase activity | | Catalysis of the reaction: non-membrane spanning protein tyrosine phosphate + H2O = non-membrane spanning protein tyrosine + phosphate. |
| GO:0051428 | | peptide hormone receptor binding | | Interacting selectively and non-covalently with a receptor for peptide hormones. |
| GO:0016791 | | phosphatase activity | | Catalysis of the hydrolysis of phosphoric monoesters, releasing inorganic phosphate. |
| GO:0046934 | | phosphatidylinositol-4,5-bisphosphate 3-kinase activity | | Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + ATP = a 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + ADP + 2 H(+). |
| GO:0043274 | | phospholipase binding | | Interacting selectively and non-covalently with any phospholipase, enzymes that catalyze of the hydrolysis of a glycerophospholipid. |
| GO:0004721 | | phosphoprotein phosphatase activity | | Catalysis of the reaction: a phosphoprotein + H2O = a protein + phosphate. Together with protein kinases, these enzymes control the state of phosphorylation of cell proteins and thereby provide an important mechanism for regulating cellular activity. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0019904 | | protein domain specific binding | | Interacting selectively and non-covalently with a specific domain of a protein. |
| GO:0004725 | | protein tyrosine phosphatase activity | | Catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate. |
| GO:0030971 | | receptor tyrosine kinase binding | | Interacting selectively and non-covalently with a receptor that possesses protein tyrosine kinase activity. |
biological process |
| GO:0060020 | | Bergmann glial cell differentiation | | The process in which neuroepithelial cells of the neural tube give rise to Brgmann glial cells, specialized bipotential progenitors cells of the cerebellum. Differentiation includes the processes involved in commitment of a cell to a specific fate. |
| GO:0000077 | | DNA damage checkpoint | | A cell cycle checkpoint that regulates progression through the cell cycle in response to DNA damage. A DNA damage checkpoint may blocks cell cycle progression (in G1, G2 or metaphase) or slow the rate at which S phase proceeds. |
| GO:0038127 | | ERBB signaling pathway | | A series of molecular signals initiated by binding of a ligand to a member of the ERBB family of receptor tyrosine kinases on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
| GO:0031295 | | T cell costimulation | | The process of providing, via surface-bound receptor-ligand pairs, a second, antigen-independent, signal in addition to that provided by the T cell receptor to augment T cell activation. |
| GO:0033277 | | abortive mitotic cell cycle | | A cell cycle in which mitosis is begun and progresses normally through the end of anaphase, but not completed, resulting in a cell with increased ploidy. |
| GO:0000187 | | activation of MAPK activity | | The initiation of the activity of the inactive enzyme MAP kinase (MAPK). |
| GO:0036302 | | atrioventricular canal development | | The progression of the atrioventricular canal over time, from its formation to the mature structure. The atrioventricular canal is the part of the heart connecting the atrium to the cardiac ventricle. |
| GO:0007409 | | axonogenesis | | De novo generation of a long process of a neuron, that carries efferent (outgoing) action potentials from the cell body towards target cells. Refers to the morphogenesis or creation of shape or form of the developing axon. |
| GO:0007420 | | brain development | | The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.). |
| GO:0021697 | | cerebellar cortex formation | | The process that gives rise to the cerebellar cortex. This process pertains to the initial formation of a structure from unspecified parts. The cerebellar cortex is a thin mantle of gray matter that covers the surface of each cerebral hemisphere. It has a characteristic morphology with convolutions (gyri) and crevices (sulci) that have specific functions. Six layers of nerve cells and the nerve pathways that connect them comprise the cerebellar cortex. Together, these regions are responsible for the processes of conscious thought, perception, emotion and memory as well as advanced motor function. |
| GO:0016311 | | dephosphorylation | | The process of removing one or more phosphoric (ester or anhydride) residues from a molecule. |
| GO:0048013 | | ephrin receptor signaling pathway | | The series of molecular signals generated as a consequence of an ephrin receptor binding to an ephrin. |
| GO:0007173 | | epidermal growth factor receptor signaling pathway | | A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription. |
| GO:0060325 | | face morphogenesis | | The process in which the anatomical structures of the face are generated and organized. The face is the ventral division of the head. |
| GO:0008543 | | fibroblast growth factor receptor signaling pathway | | The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands. |
| GO:0048806 | | genitalia development | | The process whose specific outcome is the progression of the genitalia over time, from its formation to the mature structure. |
| GO:0042593 | | glucose homeostasis | | Any process involved in the maintenance of an internal steady state of glucose within an organism or cell. |
| GO:0007507 | | heart development | | The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood. |
| GO:0048873 | | homeostasis of number of cells within a tissue | | Any biological process involved in the maintenance of the steady-state number of cells within a population of cells in a tissue. |
| GO:0042445 | | hormone metabolic process | | The chemical reactions and pathways involving any hormone, naturally occurring substances secreted by specialized cells that affects the metabolism or behavior of other cells possessing functional receptors for the hormone. |
| GO:0009755 | | hormone-mediated signaling pathway | | A series of molecular signals mediated by the detection of a hormone. |
| GO:0048839 | | inner ear development | | The process whose specific outcome is the progression of the inner ear over time, from its formation to the mature structure. |
| GO:0007229 | | integrin-mediated signaling pathway | | A series of molecular signals initiated by the binding of extracellular ligand to an integrin on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
| GO:0061582 | | intestinal epithelial cell migration | | The orderly movement of an intestinal epithelial cell from one site to another, often during the development of a multicellular organism. |
| GO:0050900 | | leukocyte migration | | The movement of a leukocyte within or between different tissues and organs of the body. |
| GO:0006629 | | lipid metabolic process | | The chemical reactions and pathways involving lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. Includes fatty acids; neutral fats, other fatty-acid esters, and soaps; long-chain (fatty) alcohols and waxes; sphingoids and other long-chain bases; glycolipids, phospholipids and sphingolipids; and carotenes, polyprenols, sterols, terpenes and other isoprenoids. |
| GO:0035855 | | megakaryocyte development | | The process whose specific outcome is the progression of a megakaryocyte cell over time, from its formation to the mature structure. Megakaryocyte development does not include the steps involved in committing a cell to a megakaryocyte fate. A megakaryocyte is a giant cell 50 to 100 micron in diameter, with a greatly lobulated nucleus, found in the bone marrow. |
| GO:0032528 | | microvillus organization | | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a microvillus, a thin cylindrical membrane-covered projection on the surface of a cell. |
| GO:0035264 | | multicellular organism growth | | The increase in size or mass of an entire multicellular organism, as opposed to cell growth. |
| GO:0048609 | | multicellular organismal reproductive process | | The process, occurring above the cellular level, that is pertinent to the reproductive function of a multicellular organism. This includes the integrated processes at the level of tissues and organs. |
| GO:0033629 | | negative regulation of cell adhesion mediated by integrin | | Any process that stops, prevents, or reduces the frequency, rate, or extent of cell adhesion mediated by integrin. |
| GO:0051463 | | negative regulation of cortisol secretion | | Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of cortisol from a cell. |
| GO:0060125 | | negative regulation of growth hormone secretion | | Any process that decreases or stops the frequency, rate or extent of the regulated release of growth hormone from a cell. |
| GO:0046888 | | negative regulation of hormone secretion | | Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of a hormone from a cell. |
| GO:0046676 | | negative regulation of insulin secretion | | Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of insulin. |
| GO:0048011 | | neurotrophin TRK receptor signaling pathway | | A series of molecular signals initiated by the binding of a neurotrophin to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription. |
| GO:0035265 | | organ growth | | The increase in size or mass of an organ. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that function together as to perform a specific function. |
| GO:0035335 | | peptidyl-tyrosine dephosphorylation | | The removal of phosphoric residues from peptidyl-O-phospho-tyrosine to form peptidyl-tyrosine. |
| GO:0046854 | | phosphatidylinositol phosphorylation | | The process of introducing one or more phosphate groups into a phosphatidylinositol, any glycerophosphoinositol having one phosphatidyl group esterified to one of the hydroxy groups of inositol. |
| GO:0036092 | | phosphatidylinositol-3-phosphate biosynthetic process | | The chemical reactions and pathways resulting in the formation of phosphatidylinositol-3-phosphate, a phosphatidylinositol monophosphate carrying the phosphate group at the 3-position. |
| GO:0048015 | | phosphatidylinositol-mediated signaling | | A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives. |
| GO:0030168 | | platelet activation | | A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug. |
| GO:0030220 | | platelet formation | | The process in which platelets bud from long processes extended by megakaryocytes. |
| GO:0048008 | | platelet-derived growth factor receptor signaling pathway | | The series of molecular signals generated as a consequence of a platelet-derived growth factor receptor binding to one of its physiological ligands. |
| GO:0070374 | | positive regulation of ERK1 and ERK2 cascade | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
| GO:2001275 | | positive regulation of glucose import in response to insulin stimulus | | Any process that activates or increases the frequency, rate or extent of glucose import in response to insulin stimulus. |
| GO:0046887 | | positive regulation of hormone secretion | | Any process that activates or increases the frequency, rate or extent of the regulated release of a hormone from a cell. |
| GO:0045931 | | positive regulation of mitotic cell cycle | | Any process that activates or increases the rate or extent of progression through the mitotic cell cycle. |
| GO:0009967 | | positive regulation of signal transduction | | Any process that activates or increases the frequency, rate or extent of signal transduction. |
| GO:0006470 | | protein dephosphorylation | | The process of removing one or more phosphoric residues from a protein. |
| GO:0033628 | | regulation of cell adhesion mediated by integrin | | Any process that modulates the frequency, rate, or extent of cell adhesion mediated by integrin. |
| GO:0040014 | | regulation of multicellular organism growth | | Any process that modulates the frequency, rate or extent of growth of the body of an organism so that it reaches its usual body size. |
| GO:0014066 | | regulation of phosphatidylinositol 3-kinase signaling | | Any process that modulates the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade. |
| GO:0043254 | | regulation of protein complex assembly | | Any process that modulates the frequency, rate or extent of protein complex assembly. |
| GO:0046825 | | regulation of protein export from nucleus | | Any process that modulates the frequency, rate or extent of the directed movement of proteins from the nucleus to the cytoplasm. |
| GO:0060338 | | regulation of type I interferon-mediated signaling pathway | | Any process that modulates the rate, frequency or extent of a type I interferon-mediated signaling pathway. A type I interferon-mediated signaling pathway is the series of molecular events generated as a consequence of a type I interferon binding to a cell surface receptor. |
| GO:0006641 | | triglyceride metabolic process | | The chemical reactions and pathways involving triglyceride, any triester of glycerol. The three fatty acid residues may all be the same or differ in any permutation. Triglycerides are important components of plant oils, animal fats and animal plasma lipoproteins. |
cellular component |
| GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| GO:0005739 | | mitochondrion | | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. |
| GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| GO:0043234 | | protein complex | | A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical. |